Lexicon Pharmaceuticals
LXRX
#6564
Rank
A$1.25 B
Marketcap
A$2.82
Share price
1.52%
Change (1 day)
68.19%
Change (1 year)

Earnings for Lexicon Pharmaceuticals (LXRX)

Earnings in 2026 (TTM): -A$39.07 Million

According to Lexicon Pharmaceuticals 's latest financial reports the company's current earnings are A$69.64 Million. In 2025 the company made an earning of -A$70.54 Million, an increase over its 2024 earnings that were of -A$0.29 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Lexicon Pharmaceuticals from 2000 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$39.07 Million-44.62%
2025 -A$70.54 Million-74.88%
2024 -A$0.29 Billion13.15%
2023 -A$0.25 Billion73.74%
2022 -A$0.15 Billion16.16%
2021 -A$0.13 Billion49.82%
2020 -A$82.07 Million-147.19%
2019 A$0.17 B-203.42%
2018 -A$0.17 Billion-15.31%
2017 -A$0.2 Billion0.2%
2016 -A$0.2 Billion2920.7%
2015 -A$6.56 Million-95.33%
2014 -A$0.15 Billion-3.61%
2013 -A$0.15 Billion-5.52%
2012 -A$0.16 Billion-4.17%
2011 -A$0.17 Billion15.5%
2010 -A$0.14 Billion8.36%
2009 -A$0.13 Billion-4.81%
2008 -A$0.14 Billion28.79%
2007 -A$0.11 Billion35.71%
2006 -A$77.39 Million52.91%
2005 -A$50.61 Million-23.89%
2004 -A$66.49 Million-24.19%
2003 -A$87.7 Million-0.48%
2002 -A$88.12 Million44.12%
2001 -A$61.15 Million23.01%
2000 -A$49.71 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Thermo Fisher Scientific
TMO
A$10.39 B-28,547.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Illumina
ILMN
A$1.62 B-4,546.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
A$7.22 B-19,865.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Ultragenyx Pharmaceutical
RARE
-A$0.76 Billion 1,956.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
A$0.26 B-830.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
A$0.11 B-404.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
-A$32.57 Million-10.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$0.54 B-1,577.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-A$20.91 Million-42.82%๐Ÿ‡บ๐Ÿ‡ธ USA